Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma

Published:2016-06 Issue:1 Volume:115 Page:66-75
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Hara Hisashi,Takahashi Tsuyoshi,Serada Satoshi,Fujimoto Minoru,Ohkawara Tomoharu,Nakatsuka Rie,Harada Emi,Nishigaki Takahiko,Takahashi Yusuke,Nojima Satoshi,Miyazaki Yasuhiro,Makino Tomoki,Kurokawa Yukinori,Yamasaki Makoto,Miyata Hiroshi,Nakajima Kiyokazu,Takiguchi Shuji,Morii Eiichi,Mori Masaki,Doki Yuichiro,Naka Tetsuji

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016183.pdf

Reference36 articles.

1. Aikawa T, Whipple CA, Lopez ME, Gunn J, Young A, Lander AD, Korc M (2008) Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. J Clin Invest 118 (1): 89–99.

2. Arita-Morioka K, Yamanaka K, Mizunoe Y, Ogura T, Sugimoto S (2015) Novel strategy for biofilm inhibition by using small molecules targeting molecular chaperone DnaK. Antimicrob Agents Chemother 59 (1): 633–641.

3. Ding K, Lopez-Burks M, Sanchez-Duran JA, Korc M, Lander AD (2005) Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J Cell Biol 171 (4): 729–738.

4. Duan L, Hu XQ, Feng DY, Lei SY, Hu GH (2013) GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer. Asian J Surg 36 (1): 7–12.

5. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (5): E359–E386.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of antitumor potential of an anti-glypican-1 monoclonal antibody in preclinical lung cancer models reveals a distinct mechanism of action;Exploration of Targeted Anti-tumor Therapy;2024-06-17

2. Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma;Neoplasia;2024-04

3. Diagnostic and prognostic value of circulating exosomal glypican-1 in pancreatic cancer: a meta-analysis;Laboratory Medicine;2024-03-12

4. Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with⁸⁹Zr or²¹¹At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma;Journal of Nuclear Medicine;2023-10-12

5. Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma;Molecular & Cellular Oncology;2023-08-15